Participate in the Avoca Group's Clinical Outsourcing Survey
Industry professionals are asked to participate in the annual Avoca Industry Survey, The State of Clinical Outsourcing, which explores outsourcing relationships, trends, practices, and approaches, and in particular, how these vary according to the type and size of company.
The survey takes approximately 15 to 20 minutes to complete. All responses are confidential and individual names will not be associated with results. The Avoca Group will express its thanks for your participation by sending you a complimentary copy of the Executive Summary, upon its release. Our findings will be presented at numerous industry conferences and will be published as well.
Please click here to take the survey.
We are pleased to have been asked to present select data gathered from this survey at IIR’s Clinical Biotech Forum, which is being held concurrently with the Partnerships In Clinical Trials meeting. For more information about IIR’s Clinical Biotech Forum West, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
